 John Rinn
Concepts (581)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 64 | 2024 | 179 | 17.510 |
Why?
| | RNA, Untranslated | 27 | 2021 | 117 | 6.210 |
Why?
| | Gene Expression Regulation | 49 | 2024 | 2536 | 4.570 |
Why?
| | Chromatin | 26 | 2023 | 477 | 4.000 |
Why?
| | RNA | 17 | 2024 | 880 | 2.870 |
Why?
| | Cell Nucleus | 13 | 2023 | 584 | 2.450 |
Why?
| | Transcription, Genetic | 29 | 2024 | 1416 | 2.450 |
Why?
| | Genome | 12 | 2022 | 276 | 2.340 |
Why?
| | Epigenesis, Genetic | 18 | 2024 | 616 | 2.240 |
Why?
| | Genome, Human | 18 | 2021 | 392 | 2.230 |
Why?
| | RNA, Messenger | 25 | 2021 | 2699 | 2.040 |
Why?
| | Enhancer Elements, Genetic | 10 | 2020 | 176 | 1.990 |
Why?
| | Promoter Regions, Genetic | 16 | 2021 | 1205 | 1.980 |
Why?
| | RNA-Binding Proteins | 15 | 2024 | 387 | 1.920 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2017 | 507 | 1.900 |
Why?
| | Repetitive Sequences, Nucleic Acid | 3 | 2021 | 111 | 1.690 |
Why?
| | Models, Genetic | 8 | 2018 | 593 | 1.650 |
Why?
| | Sequence Analysis, RNA | 14 | 2019 | 427 | 1.450 |
Why?
| | Cell Differentiation | 25 | 2023 | 1888 | 1.410 |
Why?
| | Telomerase | 4 | 2024 | 233 | 1.370 |
Why?
| | X Chromosome Inactivation | 6 | 2024 | 23 | 1.350 |
Why?
| | Gene Deletion | 6 | 2021 | 380 | 1.340 |
Why?
| | Animals | 91 | 2024 | 35286 | 1.290 |
Why?
| | Transcriptome | 11 | 2020 | 874 | 1.270 |
Why?
| | CCCTC-Binding Factor | 3 | 2024 | 14 | 1.250 |
Why?
| | Fibroblasts | 10 | 2018 | 947 | 1.210 |
Why?
| | Base Sequence | 18 | 2020 | 2146 | 1.160 |
Why?
| | Open Reading Frames | 8 | 2024 | 116 | 1.140 |
Why?
| | Genomics | 13 | 2022 | 717 | 1.140 |
Why?
| | Mice | 59 | 2024 | 16905 | 1.120 |
Why?
| | Chromosomes | 3 | 2018 | 100 | 1.100 |
Why?
| | DNA, Complementary | 8 | 2020 | 270 | 1.090 |
Why?
| | Embryonic Stem Cells | 10 | 2015 | 114 | 1.060 |
Why?
| | Genetic Loci | 7 | 2020 | 275 | 1.050 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 28 | 1.050 |
Why?
| | Gene Expression Regulation, Developmental | 16 | 2023 | 820 | 0.980 |
Why?
| | Transcription Factors | 17 | 2020 | 1644 | 0.930 |
Why?
| | Molecular Sequence Annotation | 7 | 2020 | 87 | 0.920 |
Why?
| | Gene Expression Profiling | 29 | 2020 | 1683 | 0.910 |
Why?
| | Hematopoiesis | 3 | 2021 | 183 | 0.890 |
Why?
| | DNA Damage | 2 | 2017 | 382 | 0.870 |
Why?
| | Humans | 120 | 2024 | 129144 | 0.870 |
Why?
| | Mice, Knockout | 14 | 2024 | 2871 | 0.850 |
Why?
| | Cell Line | 17 | 2024 | 2775 | 0.840 |
Why?
| | Induced Pluripotent Stem Cells | 7 | 2021 | 221 | 0.830 |
Why?
| | RNA Splicing | 6 | 2021 | 260 | 0.790 |
Why?
| | Fertility | 2 | 2020 | 155 | 0.780 |
Why?
| | Microscopy, Confocal | 3 | 2018 | 305 | 0.780 |
Why?
| | Binding Sites | 13 | 2024 | 1247 | 0.760 |
Why?
| | Pluripotent Stem Cells | 6 | 2022 | 77 | 0.760 |
Why?
| | Regulatory Elements, Transcriptional | 4 | 2020 | 20 | 0.750 |
Why?
| | Computational Biology | 7 | 2021 | 596 | 0.740 |
Why?
| | Polycomb Repressive Complex 2 | 5 | 2020 | 63 | 0.730 |
Why?
| | Ebolavirus | 4 | 2023 | 34 | 0.720 |
Why?
| | Hemorrhagic Fever, Ebola | 4 | 2023 | 35 | 0.720 |
Why?
| | Cellular Reprogramming | 4 | 2018 | 95 | 0.700 |
Why?
| | Cytoplasm | 3 | 2022 | 265 | 0.700 |
Why?
| | Evolution, Molecular | 4 | 2020 | 464 | 0.690 |
Why?
| | Sequence Deletion | 3 | 2020 | 179 | 0.680 |
Why?
| | DNA | 7 | 2022 | 1396 | 0.680 |
Why?
| | Body Patterning | 4 | 2008 | 128 | 0.670 |
Why?
| | Nucleic Acid Conformation | 7 | 2024 | 706 | 0.660 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2020 | 2059 | 0.640 |
Why?
| | K562 Cells | 5 | 2021 | 85 | 0.640 |
Why?
| | Embryonic Development | 6 | 2019 | 114 | 0.640 |
Why?
| | Repressor Proteins | 7 | 2018 | 406 | 0.630 |
Why?
| | Alleles | 6 | 2024 | 845 | 0.630 |
Why?
| | DNA-Binding Proteins | 7 | 2021 | 1445 | 0.620 |
Why?
| | Oligonucleotide Array Sequence Analysis | 17 | 2016 | 755 | 0.620 |
Why?
| | In Situ Hybridization, Fluorescence | 7 | 2021 | 312 | 0.620 |
Why?
| | Organ Specificity | 6 | 2019 | 295 | 0.600 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 776 | 0.590 |
Why?
| | Molecular Sequence Data | 10 | 2015 | 2835 | 0.580 |
Why?
| | Chromosomes, Human | 1 | 2018 | 41 | 0.580 |
Why?
| | Time-Lapse Imaging | 1 | 2018 | 20 | 0.580 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 405 | 0.580 |
Why?
| | Endogenous Retroviruses | 2 | 2022 | 34 | 0.570 |
Why?
| | Chromosomes, Human, X | 1 | 2018 | 72 | 0.570 |
Why?
| | Chromosome Aberrations | 1 | 2018 | 147 | 0.570 |
Why?
| | DNA Methylation | 8 | 2022 | 610 | 0.560 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2019 | 1336 | 0.540 |
Why?
| | Phenotype | 8 | 2024 | 3071 | 0.510 |
Why?
| | High-Throughput Nucleotide Sequencing | 6 | 2018 | 485 | 0.510 |
Why?
| | Genomic Imprinting | 3 | 2024 | 33 | 0.500 |
Why?
| | Gene Regulatory Networks | 7 | 2018 | 280 | 0.500 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 117 | 0.500 |
Why?
| | Homeodomain Proteins | 6 | 2013 | 493 | 0.500 |
Why?
| | DNA, Satellite | 1 | 2015 | 17 | 0.500 |
Why?
| | Ribonucleoproteins | 3 | 2012 | 87 | 0.500 |
Why?
| | Neoplasms | 5 | 2019 | 2442 | 0.500 |
Why?
| | DNA, Intergenic | 4 | 2011 | 24 | 0.490 |
Why?
| | Centromere | 1 | 2015 | 48 | 0.480 |
Why?
| | Plasmodium falciparum | 2 | 2015 | 29 | 0.480 |
Why?
| | Genes, Homeobox | 5 | 2013 | 51 | 0.480 |
Why?
| | Nuclear Proteins | 3 | 2016 | 658 | 0.430 |
Why?
| | DNA Transposable Elements | 1 | 2014 | 118 | 0.430 |
Why?
| | Protein Binding | 12 | 2024 | 2120 | 0.430 |
Why?
| | X Chromosome | 3 | 2024 | 52 | 0.420 |
Why?
| | Myoblasts | 3 | 2022 | 81 | 0.420 |
Why?
| | Systems Biology | 3 | 2011 | 59 | 0.420 |
Why?
| | HeLa Cells | 8 | 2021 | 611 | 0.420 |
Why?
| | Proteins | 7 | 2024 | 941 | 0.420 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2014 | 138 | 0.410 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2014 | 131 | 0.410 |
Why?
| | RNA Interference | 7 | 2021 | 449 | 0.410 |
Why?
| | Adipogenesis | 1 | 2013 | 50 | 0.400 |
Why?
| | Retroelements | 1 | 2012 | 44 | 0.400 |
Why?
| | Homeostasis | 4 | 2021 | 605 | 0.400 |
Why?
| | HEK293 Cells | 7 | 2021 | 695 | 0.390 |
Why?
| | Cells, Cultured | 16 | 2021 | 4075 | 0.390 |
Why?
| | Skin | 2 | 2008 | 726 | 0.390 |
Why?
| | Brain | 2 | 2015 | 2668 | 0.390 |
Why?
| | Epidermis | 2 | 2012 | 155 | 0.370 |
Why?
| | RNA Stability | 5 | 2021 | 102 | 0.370 |
Why?
| | Human Embryonic Stem Cells | 2 | 2021 | 22 | 0.360 |
Why?
| | Introns | 5 | 2021 | 251 | 0.360 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 2023 | 87 | 0.350 |
Why?
| | Histones | 11 | 2021 | 588 | 0.350 |
Why?
| | Conserved Sequence | 6 | 2020 | 227 | 0.340 |
Why?
| | Telomere | 2 | 2019 | 232 | 0.340 |
Why?
| | Down-Regulation | 3 | 2016 | 636 | 0.340 |
Why?
| | Single-Cell Analysis | 5 | 2020 | 274 | 0.330 |
Why?
| | Mouse Embryonic Stem Cells | 3 | 2020 | 30 | 0.330 |
Why?
| | Muscle Development | 3 | 2022 | 103 | 0.330 |
Why?
| | Chromosomes, Human, Pair 22 | 4 | 2004 | 40 | 0.330 |
Why?
| | Gene Library | 4 | 2018 | 115 | 0.320 |
Why?
| | Sex Characteristics | 2 | 2005 | 736 | 0.320 |
Why?
| | Gene Editing | 2 | 2021 | 67 | 0.320 |
Why?
| | CRISPR-Cas Systems | 3 | 2021 | 108 | 0.310 |
Why?
| | MicroRNAs | 8 | 2021 | 676 | 0.310 |
Why?
| | Mammals | 5 | 2021 | 272 | 0.310 |
Why?
| | Nucleotide Motifs | 3 | 2017 | 33 | 0.300 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2045 | 0.300 |
Why?
| | Cell Lineage | 5 | 2021 | 331 | 0.290 |
Why?
| | Immunity, Innate | 3 | 2019 | 803 | 0.290 |
Why?
| | Lymphopoiesis | 2 | 2021 | 25 | 0.280 |
Why?
| | Chromatin Assembly and Disassembly | 5 | 2017 | 100 | 0.280 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 3 | 2022 | 31 | 0.280 |
Why?
| | Wnt Proteins | 1 | 2008 | 127 | 0.270 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 748 | 0.260 |
Why?
| | Reproducibility of Results | 6 | 2021 | 3077 | 0.260 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 3 | 2022 | 17 | 0.260 |
Why?
| | HCT116 Cells | 3 | 2021 | 78 | 0.250 |
Why?
| | MAP Kinase Signaling System | 1 | 2007 | 312 | 0.240 |
Why?
| | Exons | 4 | 2016 | 341 | 0.240 |
Why?
| | Male | 21 | 2024 | 63456 | 0.240 |
Why?
| | Databases, Genetic | 4 | 2020 | 230 | 0.240 |
Why?
| | Genes, X-Linked | 1 | 2024 | 17 | 0.230 |
Why?
| | Myosin Heavy Chains | 2 | 2021 | 170 | 0.230 |
Why?
| | Signal Transduction | 11 | 2021 | 4919 | 0.220 |
Why?
| | Genitalia | 1 | 2004 | 30 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 1 | 2008 | 635 | 0.220 |
Why?
| | Motor Neurons | 3 | 2015 | 234 | 0.220 |
Why?
| | Gene Knockdown Techniques | 4 | 2013 | 316 | 0.220 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2023 | 3 | 0.220 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2019 | 751 | 0.220 |
Why?
| | Female | 23 | 2024 | 68494 | 0.210 |
Why?
| | Alternative Splicing | 2 | 2018 | 216 | 0.210 |
Why?
| | Cluster Analysis | 5 | 2015 | 480 | 0.210 |
Why?
| | Databases, Nucleic Acid | 2 | 2021 | 33 | 0.200 |
Why?
| | Zebrafish | 4 | 2013 | 458 | 0.200 |
Why?
| | Plasmids | 1 | 2023 | 358 | 0.200 |
Why?
| | NF-kappa B | 4 | 2020 | 663 | 0.200 |
Why?
| | Mitosis | 2 | 2021 | 180 | 0.190 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 171 | 0.190 |
Why?
| | Ribonucleases | 2 | 2019 | 54 | 0.190 |
Why?
| | RNA Transport | 3 | 2016 | 23 | 0.190 |
Why?
| | Genetic Techniques | 2 | 2013 | 63 | 0.190 |
Why?
| | Gene Targeting | 1 | 2021 | 82 | 0.190 |
Why?
| | Mice, Inbred Strains | 2 | 2019 | 406 | 0.180 |
Why?
| | Cell Compartmentation | 1 | 2021 | 52 | 0.180 |
Why?
| | Ectoderm | 1 | 2021 | 50 | 0.180 |
Why?
| | Research Report | 1 | 2021 | 76 | 0.180 |
Why?
| | Genetic Association Studies | 3 | 2014 | 361 | 0.180 |
Why?
| | Stem Cells | 3 | 2022 | 574 | 0.180 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2022 | 187 | 0.180 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 946 | 0.180 |
Why?
| | Cardiac Myosins | 1 | 2021 | 30 | 0.180 |
Why?
| | Ikaros Transcription Factor | 1 | 2021 | 23 | 0.180 |
Why?
| | Receptor, Insulin | 1 | 2021 | 99 | 0.180 |
Why?
| | Epigenomics | 2 | 2011 | 110 | 0.170 |
Why?
| | Spermatogenesis | 1 | 2020 | 62 | 0.170 |
Why?
| | Lipopolysaccharides | 3 | 2019 | 877 | 0.170 |
Why?
| | Placenta | 3 | 2021 | 723 | 0.170 |
Why?
| | Polycomb-Group Proteins | 3 | 2010 | 28 | 0.170 |
Why?
| | Telomere Homeostasis | 1 | 2020 | 29 | 0.170 |
Why?
| | Protein Domains | 2 | 2020 | 253 | 0.170 |
Why?
| | Eukaryotic Cells | 1 | 2020 | 33 | 0.170 |
Why?
| | Congresses as Topic | 1 | 2021 | 216 | 0.170 |
Why?
| | RNA Precursors | 1 | 2021 | 147 | 0.170 |
Why?
| | Species Specificity | 1 | 2021 | 574 | 0.160 |
Why?
| | Preimplantation Diagnosis | 1 | 2019 | 5 | 0.160 |
Why?
| | Genome-Wide Association Study | 4 | 2020 | 1326 | 0.160 |
Why?
| | Dactinomycin | 1 | 2019 | 28 | 0.160 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 57 | 0.160 |
Why?
| | Immunoprecipitation | 2 | 2024 | 157 | 0.160 |
Why?
| | Embryo Implantation | 1 | 2019 | 28 | 0.160 |
Why?
| | RNA Processing, Post-Transcriptional | 3 | 2018 | 87 | 0.160 |
Why?
| | Mice, Inbred C57BL | 10 | 2024 | 5438 | 0.160 |
Why?
| | Drug Tolerance | 1 | 2019 | 90 | 0.160 |
Why?
| | Organelles | 2 | 2017 | 54 | 0.160 |
Why?
| | Fertilization in Vitro | 1 | 2019 | 76 | 0.160 |
Why?
| | RNA, Fungal | 2 | 2010 | 67 | 0.160 |
Why?
| | Structure-Activity Relationship | 1 | 2020 | 543 | 0.160 |
Why?
| | Apoptosis | 4 | 2018 | 2491 | 0.150 |
Why?
| | Time Factors | 4 | 2024 | 6541 | 0.150 |
Why?
| | Protein Conformation | 2 | 2021 | 860 | 0.150 |
Why?
| | Cell Line, Tumor | 4 | 2021 | 3186 | 0.150 |
Why?
| | Pattern Recognition, Automated | 1 | 2019 | 75 | 0.150 |
Why?
| | Mutation | 6 | 2024 | 3705 | 0.150 |
Why?
| | Transgenes | 3 | 2020 | 177 | 0.150 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2018 | 21 | 0.150 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2018 | 28 | 0.150 |
Why?
| | Cell Proliferation | 7 | 2020 | 2368 | 0.150 |
Why?
| | Adipocytes | 1 | 2020 | 204 | 0.150 |
Why?
| | Binding, Competitive | 2 | 2020 | 206 | 0.150 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2018 | 54 | 0.150 |
Why?
| | HMGA2 Protein | 1 | 2018 | 9 | 0.150 |
Why?
| | Molecular Imaging | 1 | 2018 | 54 | 0.150 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 285 | 0.150 |
Why?
| | Cell Nucleolus | 1 | 2018 | 17 | 0.150 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2017 | 326 | 0.140 |
Why?
| | Translocation, Genetic | 1 | 2018 | 96 | 0.140 |
Why?
| | Cyclooxygenase 2 | 1 | 2018 | 176 | 0.140 |
Why?
| | Macaca mulatta | 3 | 2023 | 149 | 0.140 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2018 | 129 | 0.140 |
Why?
| | Lymphocytes | 2 | 2017 | 378 | 0.140 |
Why?
| | Immunity | 1 | 2018 | 138 | 0.140 |
Why?
| | Consensus Sequence | 2 | 2016 | 73 | 0.140 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 247 | 0.140 |
Why?
| | Pyramidal Tracts | 2 | 2014 | 26 | 0.140 |
Why?
| | Retinal Pigment Epithelium | 1 | 2018 | 70 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2021 | 260 | 0.140 |
Why?
| | High-Throughput Screening Assays | 2 | 2016 | 138 | 0.140 |
Why?
| | Staining and Labeling | 1 | 2017 | 141 | 0.140 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 351 | 0.140 |
Why?
| | Splicing Factor U2AF | 1 | 2016 | 16 | 0.130 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2016 | 38 | 0.130 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 81 | 0.130 |
Why?
| | Histone Deacetylases | 1 | 2018 | 212 | 0.130 |
Why?
| | Kidney | 1 | 2004 | 1384 | 0.130 |
Why?
| | Genetic Testing | 1 | 2019 | 428 | 0.130 |
Why?
| | Genotype | 1 | 2021 | 1833 | 0.130 |
Why?
| | Histocompatibility, Maternal-Fetal | 1 | 2016 | 2 | 0.130 |
Why?
| | HLA-G Antigens | 1 | 2016 | 2 | 0.130 |
Why?
| | GTP-Binding Protein gamma Subunits | 1 | 2016 | 5 | 0.130 |
Why?
| | Support Vector Machine | 1 | 2016 | 37 | 0.130 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2018 | 740 | 0.130 |
Why?
| | Chromatin Assembly Factor-1 | 1 | 2015 | 12 | 0.130 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2016 | 113 | 0.130 |
Why?
| | Doxorubicin | 1 | 2017 | 328 | 0.120 |
Why?
| | Myocardium | 1 | 2021 | 978 | 0.120 |
Why?
| | Liver | 1 | 2004 | 1839 | 0.120 |
Why?
| | Methylation | 5 | 2020 | 230 | 0.120 |
Why?
| | PTEN Phosphohydrolase | 2 | 2016 | 161 | 0.120 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2015 | 19 | 0.120 |
Why?
| | Chondrocytes | 1 | 2018 | 203 | 0.120 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 257 | 0.120 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2015 | 22 | 0.120 |
Why?
| | Nervous System | 1 | 2015 | 67 | 0.120 |
Why?
| | rho GTP-Binding Proteins | 1 | 2016 | 60 | 0.120 |
Why?
| | Pseudogenes | 2 | 2014 | 18 | 0.120 |
Why?
| | Immunohistochemistry | 3 | 2015 | 1678 | 0.120 |
Why?
| | Genes | 1 | 2015 | 227 | 0.120 |
Why?
| | Gene Expression | 4 | 2015 | 1463 | 0.120 |
Why?
| | beta-Galactosidase | 1 | 2015 | 77 | 0.120 |
Why?
| | RNA, Protozoan | 1 | 2015 | 58 | 0.120 |
Why?
| | Erythrocytes | 1 | 2020 | 673 | 0.120 |
Why?
| | Myeloid Cells | 1 | 2016 | 141 | 0.120 |
Why?
| | STAT3 Transcription Factor | 1 | 2016 | 194 | 0.120 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 161 | 0.120 |
Why?
| | Gene Silencing | 2 | 2013 | 189 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 381 | 0.120 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 101 | 0.120 |
Why?
| | RNA, Catalytic | 1 | 2015 | 185 | 0.110 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2018 | 431 | 0.110 |
Why?
| | Molecular Biology | 1 | 2015 | 56 | 0.110 |
Why?
| | Neocortex | 1 | 2014 | 32 | 0.110 |
Why?
| | Lysine | 3 | 2020 | 286 | 0.110 |
Why?
| | Pyramidal Cells | 1 | 2014 | 69 | 0.110 |
Why?
| | Neurons | 2 | 2021 | 1493 | 0.110 |
Why?
| | Kinetics | 1 | 2018 | 1643 | 0.110 |
Why?
| | Protein Footprinting | 1 | 2014 | 11 | 0.110 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2018 | 592 | 0.110 |
Why?
| | Pregnancy | 4 | 2023 | 6392 | 0.110 |
Why?
| | Trophoblasts | 1 | 2016 | 190 | 0.110 |
Why?
| | Neurotransmitter Agents | 1 | 2014 | 81 | 0.110 |
Why?
| | Keratinocytes | 2 | 2012 | 242 | 0.110 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 1056 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 37 | 0.110 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2011 | 151 | 0.110 |
Why?
| | Leukocytes, Mononuclear | 1 | 2016 | 545 | 0.110 |
Why?
| | Nerve Tissue Proteins | 2 | 2014 | 569 | 0.100 |
Why?
| | Information Theory | 1 | 2013 | 5 | 0.100 |
Why?
| | Neuronal Plasticity | 1 | 2015 | 279 | 0.100 |
Why?
| | Fetus | 1 | 2017 | 770 | 0.100 |
Why?
| | Nervous System Diseases | 1 | 2015 | 251 | 0.100 |
Why?
| | Ubiquitination | 1 | 2013 | 98 | 0.100 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 65 | 0.100 |
Why?
| | Protein Array Analysis | 1 | 2012 | 56 | 0.100 |
Why?
| | Registries | 1 | 2020 | 1895 | 0.100 |
Why?
| | Adipocytes, Brown | 1 | 2012 | 7 | 0.100 |
Why?
| | Mice, Transgenic | 5 | 2020 | 2117 | 0.100 |
Why?
| | Models, Biological | 1 | 2019 | 1722 | 0.100 |
Why?
| | Adipocytes, White | 1 | 2012 | 17 | 0.100 |
Why?
| | Biological Evolution | 1 | 2015 | 432 | 0.100 |
Why?
| | Ribosomes | 1 | 2013 | 164 | 0.100 |
Why?
| | Genes, Overlapping | 1 | 2011 | 2 | 0.090 |
Why?
| | Genome, Protozoan | 1 | 2011 | 3 | 0.090 |
Why?
| | Genes, Protozoan | 1 | 2011 | 11 | 0.090 |
Why?
| | Models, Statistical | 2 | 2024 | 623 | 0.090 |
Why?
| | Mitochondria | 2 | 2020 | 876 | 0.090 |
Why?
| | Disease | 1 | 2012 | 95 | 0.090 |
Why?
| | Artifacts | 1 | 2011 | 126 | 0.090 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2010 | 5 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2011 | 332 | 0.090 |
Why?
| | Colonic Neoplasms | 1 | 2013 | 241 | 0.090 |
Why?
| | Argonaute Proteins | 3 | 2016 | 27 | 0.080 |
Why?
| | Sexual Maturation | 1 | 2010 | 52 | 0.080 |
Why?
| | Insulin | 2 | 2018 | 2325 | 0.080 |
Why?
| | Octamer Transcription Factor-3 | 2 | 2021 | 16 | 0.080 |
Why?
| | Body Size | 1 | 2010 | 104 | 0.080 |
Why?
| | Thymus Gland | 2 | 2008 | 308 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2016 | 891 | 0.080 |
Why?
| | Saccharomyces cerevisiae | 2 | 2010 | 530 | 0.080 |
Why?
| | Chromosome Mapping | 3 | 2004 | 504 | 0.070 |
Why?
| | Prostatic Neoplasms | 1 | 2016 | 996 | 0.070 |
Why?
| | Zebrafish Proteins | 2 | 2010 | 266 | 0.070 |
Why?
| | Viruses | 1 | 2009 | 100 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2010 | 210 | 0.070 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2008 | 18 | 0.070 |
Why?
| | Proteome | 1 | 2012 | 438 | 0.070 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2009 | 70 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2009 | 302 | 0.070 |
Why?
| | Myosin Type V | 1 | 2008 | 9 | 0.070 |
Why?
| | Wnt-5a Protein | 1 | 2008 | 21 | 0.070 |
Why?
| | Chromosome Disorders | 1 | 2008 | 40 | 0.070 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 607 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2020 | 2056 | 0.070 |
Why?
| | Cell Survival | 3 | 2016 | 1074 | 0.070 |
Why?
| | Keratins | 1 | 2008 | 175 | 0.070 |
Why?
| | Autoantigens | 2 | 2008 | 419 | 0.070 |
Why?
| | Genes, Reporter | 2 | 2020 | 265 | 0.070 |
Why?
| | Zinc Fingers | 1 | 2007 | 45 | 0.070 |
Why?
| | Peptides | 1 | 2012 | 923 | 0.070 |
Why?
| | Software | 1 | 2012 | 606 | 0.070 |
Why?
| | Retinol-Binding Proteins | 1 | 2006 | 14 | 0.070 |
Why?
| | Bacteria | 2 | 2013 | 813 | 0.070 |
Why?
| | Epithelium | 1 | 2008 | 311 | 0.070 |
Why?
| | Protozoan Proteins | 1 | 2007 | 75 | 0.070 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 169 | 0.070 |
Why?
| | Breast Neoplasms | 2 | 2016 | 2127 | 0.070 |
Why?
| | Wound Healing | 1 | 2009 | 305 | 0.070 |
Why?
| | ras Proteins | 1 | 2007 | 144 | 0.070 |
Why?
| | Algorithms | 1 | 2014 | 1613 | 0.060 |
Why?
| | Eye Proteins | 1 | 2006 | 88 | 0.060 |
Why?
| | Dendritic Cells | 1 | 2009 | 479 | 0.060 |
Why?
| | Up-Regulation | 2 | 2020 | 838 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2006 | 315 | 0.060 |
Why?
| | Monocytes | 2 | 2020 | 551 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2021 | 591 | 0.060 |
Why?
| | Quantitative Trait Loci | 2 | 2020 | 352 | 0.060 |
Why?
| | Neoplastic Stem Cells | 1 | 2009 | 378 | 0.060 |
Why?
| | Transcortin | 1 | 2004 | 16 | 0.060 |
Why?
| | RNA Polymerase II | 2 | 2023 | 317 | 0.060 |
Why?
| | Levivirus | 1 | 2024 | 18 | 0.060 |
Why?
| | Biophysical Phenomena | 1 | 2024 | 64 | 0.060 |
Why?
| | Serpins | 1 | 2004 | 31 | 0.060 |
Why?
| | Metabolic Clearance Rate | 1 | 2004 | 117 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2008 | 383 | 0.060 |
Why?
| | Testis | 1 | 2004 | 144 | 0.050 |
Why?
| | Hypothalamus | 1 | 2004 | 149 | 0.050 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 141 | 0.050 |
Why?
| | Virus Internalization | 1 | 2023 | 47 | 0.050 |
Why?
| | Selection, Genetic | 1 | 2005 | 249 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2016 | 132 | 0.050 |
Why?
| | Endoderm | 1 | 2023 | 19 | 0.050 |
Why?
| | SOXF Transcription Factors | 1 | 2023 | 16 | 0.050 |
Why?
| | Autoimmune Diseases | 1 | 2006 | 426 | 0.050 |
Why?
| | Poly A | 1 | 2003 | 48 | 0.050 |
Why?
| | Ovary | 1 | 2004 | 207 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2022 | 15 | 0.050 |
Why?
| | Neoplasm Invasiveness | 2 | 2016 | 481 | 0.050 |
Why?
| | Cytoskeletal Proteins | 2 | 2012 | 148 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 380 | 0.050 |
Why?
| | Histone Demethylases | 2 | 2015 | 31 | 0.050 |
Why?
| | Macrophages | 2 | 2020 | 1481 | 0.050 |
Why?
| | RNA, Small Untranslated | 1 | 2021 | 15 | 0.050 |
Why?
| | Disease Models, Animal | 4 | 2017 | 4056 | 0.050 |
Why?
| | Primates | 1 | 2022 | 120 | 0.040 |
Why?
| | Smad1 Protein | 1 | 2020 | 18 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2020 | 7 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 201 | 0.040 |
Why?
| | Oligonucleotide Probes | 2 | 2015 | 50 | 0.040 |
Why?
| | Cochlear Nucleus | 1 | 2000 | 5 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 1000 | 0.040 |
Why?
| | Gene Ontology | 1 | 2020 | 49 | 0.040 |
Why?
| | Bystander Effect | 1 | 2020 | 15 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 183 | 0.040 |
Why?
| | DNA Replication Timing | 1 | 2020 | 1 | 0.040 |
Why?
| | DNA Footprinting | 1 | 2020 | 33 | 0.040 |
Why?
| | Transposases | 1 | 2020 | 16 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 619 | 0.040 |
Why?
| | Deoxyribonuclease I | 1 | 2020 | 38 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 151 | 0.040 |
Why?
| | CpG Islands | 2 | 2015 | 152 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2000 | 50 | 0.040 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2020 | 90 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 184 | 0.040 |
Why?
| | Genetic Variation | 1 | 2005 | 937 | 0.040 |
Why?
| | Cell Respiration | 1 | 2020 | 98 | 0.040 |
Why?
| | Static Electricity | 1 | 2020 | 116 | 0.040 |
Why?
| | Karyotype | 1 | 2019 | 17 | 0.040 |
Why?
| | Karyotyping | 1 | 2019 | 107 | 0.040 |
Why?
| | Potassium Channels | 1 | 2000 | 149 | 0.040 |
Why?
| | Blastocyst | 1 | 2019 | 47 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 217 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 191 | 0.040 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2020 | 363 | 0.040 |
Why?
| | Cell Movement | 2 | 2016 | 944 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 332 | 0.040 |
Why?
| | Interphase | 1 | 2018 | 31 | 0.040 |
Why?
| | Internet | 1 | 2003 | 615 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2735 | 0.040 |
Why?
| | HL-60 Cells | 1 | 2018 | 34 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2014 | 1155 | 0.040 |
Why?
| | Regenerative Medicine | 1 | 2018 | 45 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 10 | 0.040 |
Why?
| | Genes, Switch | 1 | 2018 | 6 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2018 | 104 | 0.040 |
Why?
| | Cytarabine | 1 | 2018 | 57 | 0.040 |
Why?
| | GATA4 Transcription Factor | 1 | 2018 | 18 | 0.040 |
Why?
| | Biotinylation | 1 | 2017 | 29 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2018 | 61 | 0.040 |
Why?
| | Antigens, CD | 1 | 2020 | 487 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 59 | 0.040 |
Why?
| | Inhibitor of Differentiation Protein 2 | 1 | 2017 | 5 | 0.040 |
Why?
| | Epistasis, Genetic | 1 | 2018 | 70 | 0.040 |
Why?
| | STAT5 Transcription Factor | 1 | 2017 | 48 | 0.030 |
Why?
| | Lymphocyte Subsets | 1 | 2017 | 84 | 0.030 |
Why?
| | Oncogene Protein pp60(v-src) | 1 | 2016 | 5 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2021 | 499 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2020 | 497 | 0.030 |
Why?
| | Pharmacogenetics | 1 | 2018 | 172 | 0.030 |
Why?
| | Mice, Nude | 2 | 2010 | 682 | 0.030 |
Why?
| | Macaca | 1 | 2016 | 54 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2016 | 114 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 506 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2016 | 44 | 0.030 |
Why?
| | Phosphorylation | 1 | 2021 | 1710 | 0.030 |
Why?
| | Immunogenetic Phenomena | 1 | 2016 | 7 | 0.030 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 64 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1028 | 0.030 |
Why?
| | Cell Fractionation | 1 | 2016 | 56 | 0.030 |
Why?
| | Lipids | 1 | 2020 | 625 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2020 | 742 | 0.030 |
Why?
| | RNA Polymerase III | 1 | 2016 | 26 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1084 | 0.030 |
Why?
| | Mice, Inbred BALB C | 2 | 2010 | 1246 | 0.030 |
Why?
| | Mice, Inbred NOD | 2 | 2008 | 587 | 0.030 |
Why?
| | DNA Repair | 1 | 2017 | 206 | 0.030 |
Why?
| | Heterochromatin | 1 | 2015 | 41 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2015 | 129 | 0.030 |
Why?
| | Matrix Attachment Region Binding Proteins | 1 | 2014 | 4 | 0.030 |
Why?
| | Transcriptional Activation | 2 | 2010 | 367 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1485 | 0.030 |
Why?
| | Blood | 1 | 2015 | 105 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 109 | 0.030 |
Why?
| | Genes, Suppressor | 1 | 2014 | 5 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2014 | 66 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 223 | 0.030 |
Why?
| | Transfection | 1 | 2016 | 914 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1054 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 388 | 0.030 |
Why?
| | Killer Cells, Natural | 1 | 2017 | 426 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2020 | 873 | 0.030 |
Why?
| | Autoimmunity | 1 | 2020 | 862 | 0.030 |
Why?
| | Precipitin Tests | 2 | 2004 | 97 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2015 | 218 | 0.030 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2017 | 269 | 0.030 |
Why?
| | RNA Editing | 1 | 2014 | 20 | 0.030 |
Why?
| | Computer Simulation | 1 | 2018 | 937 | 0.030 |
Why?
| | Nucleosomes | 1 | 2015 | 137 | 0.030 |
Why?
| | Membrane Transport Proteins | 1 | 2015 | 149 | 0.030 |
Why?
| | Cell Death | 1 | 2015 | 354 | 0.030 |
Why?
| | Eosinophils | 1 | 2016 | 324 | 0.030 |
Why?
| | Virus Replication | 1 | 2016 | 450 | 0.030 |
Why?
| | RNA Isoforms | 1 | 2013 | 1 | 0.030 |
Why?
| | Neurogenesis | 1 | 2014 | 124 | 0.030 |
Why?
| | HapMap Project | 1 | 2013 | 5 | 0.030 |
Why?
| | Blotting, Western | 1 | 2016 | 1202 | 0.030 |
Why?
| | Toll-Like Receptor 5 | 1 | 2013 | 14 | 0.030 |
Why?
| | Ataxins | 1 | 2013 | 3 | 0.030 |
Why?
| | Ataxin-1 | 1 | 2013 | 4 | 0.030 |
Why?
| | RNA Cap-Binding Proteins | 1 | 2013 | 4 | 0.030 |
Why?
| | ELAV Proteins | 1 | 2013 | 14 | 0.030 |
Why?
| | Flagellin | 1 | 2013 | 17 | 0.030 |
Why?
| | Lung | 2 | 2018 | 3927 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2013 | 79 | 0.030 |
Why?
| | Cell Cycle | 1 | 2016 | 588 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2013 | 368 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 140 | 0.020 |
Why?
| | Cytokines | 1 | 2020 | 2012 | 0.020 |
Why?
| | Multigene Family | 1 | 2013 | 199 | 0.020 |
Why?
| | Codon | 1 | 2012 | 86 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 314 | 0.020 |
Why?
| | Acetylation | 1 | 2013 | 244 | 0.020 |
Why?
| | History, 21st Century | 1 | 2013 | 183 | 0.020 |
Why?
| | Tretinoin | 1 | 2013 | 130 | 0.020 |
Why?
| | RNA Folding | 1 | 2012 | 36 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2272 | 0.020 |
Why?
| | Genetic Research | 1 | 2011 | 16 | 0.020 |
Why?
| | History, 20th Century | 1 | 2013 | 291 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 32 | 0.020 |
Why?
| | Adipose Tissue, White | 1 | 2012 | 37 | 0.020 |
Why?
| | 3T3 Cells | 1 | 2012 | 153 | 0.020 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2012 | 49 | 0.020 |
Why?
| | Adipose Tissue, Brown | 1 | 2012 | 51 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2011 | 41 | 0.020 |
Why?
| | Data Mining | 1 | 2012 | 109 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2012 | 192 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 154 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 259 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2013 | 311 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2013 | 181 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 360 | 0.020 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 217 | 0.020 |
Why?
| | Skin Diseases | 1 | 2012 | 143 | 0.020 |
Why?
| | Neutrophils | 1 | 2016 | 1207 | 0.020 |
Why?
| | PPAR gamma | 1 | 2012 | 183 | 0.020 |
Why?
| | Gene Dosage | 1 | 2011 | 143 | 0.020 |
Why?
| | Zygote | 1 | 2010 | 13 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2013 | 455 | 0.020 |
Why?
| | Bias | 1 | 2011 | 196 | 0.020 |
Why?
| | Lipopeptides | 1 | 2009 | 13 | 0.020 |
Why?
| | Career Choice | 1 | 2011 | 206 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2010 | 256 | 0.020 |
Why?
| | Poly I-C | 1 | 2009 | 62 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2009 | 76 | 0.020 |
Why?
| | Oncogene Proteins v-myb | 1 | 2009 | 1 | 0.020 |
Why?
| | HMGB3 Protein | 1 | 2009 | 1 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 3963 | 0.020 |
Why?
| | Mice, SCID | 1 | 2010 | 350 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 297 | 0.020 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2009 | 50 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2009 | 179 | 0.020 |
Why?
| | Random Allocation | 1 | 2009 | 346 | 0.020 |
Why?
| | Lacrimal Apparatus | 1 | 2008 | 7 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2009 | 113 | 0.020 |
Why?
| | Models, Animal | 1 | 2010 | 376 | 0.020 |
Why?
| | Salivary Glands | 1 | 2008 | 29 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2009 | 116 | 0.020 |
Why?
| | Polyribosomes | 1 | 2008 | 21 | 0.020 |
Why?
| | Vacuoles | 1 | 2008 | 36 | 0.020 |
Why?
| | Secretory Vesicles | 1 | 2008 | 24 | 0.020 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 16 | 0.020 |
Why?
| | Leukocytes | 1 | 2009 | 306 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2008 | 216 | 0.020 |
Why?
| | Eye | 1 | 2008 | 104 | 0.020 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2009 | 200 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2008 | 161 | 0.020 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2007 | 60 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2007 | 166 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 510 | 0.020 |
Why?
| | Actins | 1 | 2008 | 411 | 0.020 |
Why?
| | Uveitis | 1 | 2006 | 127 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1869 | 0.020 |
Why?
| | Glucose | 1 | 2010 | 1000 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 2004 | 189 | 0.010 |
Why?
| | Colforsin | 1 | 2004 | 50 | 0.010 |
Why?
| | Transcription Factor RelA | 1 | 2003 | 83 | 0.010 |
Why?
| | Quality Improvement | 1 | 2011 | 1095 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2622 | 0.010 |
Why?
| | Prognosis | 1 | 2010 | 3766 | 0.010 |
Why?
| | Shal Potassium Channels | 1 | 2000 | 6 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 2000 | 52 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 2098 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1304 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2000 | 296 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1201 | 0.010 |
Why?
| | Middle Aged | 1 | 2010 | 31050 | 0.000 |
Why?
|
|
Rinn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|